Home/Pipeline/Biologics Delivery Program

Biologics Delivery Program

High-viscosity biologics (e.g., for Rheumatoid Arthritis, Psoriasis)

DevelopmentActive

Key Facts

Indication
High-viscosity biologics (e.g., for Rheumatoid Arthritis, Psoriasis)
Phase
Development
Status
Active
Company

About Tecuro

Tecuro is a private, pre-revenue biotech firm pioneering a novel needle-free injection platform. The company's core technology, the Tecuro Injector, utilizes a high-speed liquid jet to deliver a wide range of therapeutics intradermally, subcutaneously, or intramuscularly without a needle, addressing significant unmet needs in patient compliance, safety, and precise dosing. Initially targeting the large and growing market for biologics and vaccines, Tecuro's platform has broad potential across multiple therapeutic areas. The company appears to be in a late development/pre-commercial stage, seeking partnerships to advance its lead programs toward regulatory approval and market entry.

View full company profile